ASSOCIATIONS BETWEEN CLINICAL COURSE, LEFT VENTRICULAR HYPERTROPHY SEVERITY AND ACE GENE I/D POLYMORPHISM IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND HYPERTENSIVE HEART

The manifold studies on ACE gene impact on left ventricular hypertrophy (LVH) development in hypertrophic cardiomyopathy (HCMP) and arterial hypertension (AH) have provided too contradictory results to clarify the association between ACE gene I/D polymorphism and cardiovascular pathology in these nosologic forms. The study aimed to analyse the associations between clinical course, LVH severity, and ACE gene polymorphism among HCMP and AH patients. In total, 35 HCMP patients and 33 individuals with long AH duration and LVH were examined. ACE gene I/D polymorphism was studied by PCR method. Electrocardiography (ECG) and echocardiography (EchoCG) were also performed. In HCMP, ID type of ACE gene was associated with more severe ECG signs of LVH (voltage, ST-T changes), comparing to DD type. II Type was linked to greater myocardial mass, interventricular septum thickness, and left atrium dilatation, comparing to DD type. II allele was regarded as a risk allele. In AH and LVH, ACE gene ID type was associated with a tendency towards greater interventricular septum thickness, while II allele was very rare (5,4%) and linked to LVH absence. No relations to clinical course and ECG changes were observed.

Hypertrophic cardiomyopathy, hypertensive heart, ID polymorphism, left ventricular hypertrophy, associations

1. Березнева Н.А Арсеньева Е.Н., Юрявичус А.И., и.др. Ренинангиотензиновая система у детей с гипертрофической кардиомиопатией. Тезисы докладов второй научной конференции «Эндокринная регуляция физиологических функций в норме и патологии». Россия, Новосибирск (15-17 октября 2002 г). Информационная система «Конференции» http://conf.msu.ru

2. Караулова Ю.Л., Павлова А.В. Моисеев В.С.и др. Изучение клинико-генетических детерминант гипертрофии левого желудочка у больных артериальной гипертонией и гипертрофической кардиомиопатией // Практикующий врач 2006, 1, стр. 58–63.

3. Моисеев В.С., Демуров Л.М., Кабалава Ж.Д. и др. Полиморфизм гена ангиотензинпревращающего фермента у пациентов с гипертоничской болезнью, гипертрофией левого желудочка и развитием инфаркта миокарда в молодом возрасте // Тер. архив, 1997, 9, стр. 18 -23,3.

4. Чистяков Д.А., Демуров Л.М., Кондратьев Я.Ю. и др. Полиморфизм гена ангиотензинпревращающего фермента при артериальной гипертонии и сердечно-сосудистых заболеваниях в московской популяции // Мол. биол. 1998; 32 (3): 410–415.

5. Danser A, Derks F, Nense H. Angiotensinogen( M235T) and angiotensin I-converting enzyme gene( I/D) polymorphisms in association with plasma renin and protein levels // J. Hypertens. 1998; 16: 1879–1883.

6. Jalil JE, Piddo AM, Cordova S. et al. Prevalence of the angiotensin I converting enzyme insertion/deletion polymorphism, plasma angiotensin converting enzyme activity, and left ventricular mass in a normotensive Chilean population// Am. J. Hypertens. 1999; 12: 697–704.

7. Meghan J. Perkins1,, Sara L. et al. Gene-specific modifying effects of pro-LVH polymorphisms involving the renin–angiotensin– aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy// Eur.n Heart J.2005 26(22):24572–462.

8. Rai TS, Dhandapany PS, Ahluwalia TS. ACE I/D polymorphism in Indian patients with hypertrophic cardiomyopathy and dilated cardiomyopathy et al.// Mol Cell Biochem. 2008 Apr;311(12– ):677–2.8.

9. Yildis A., Akkaya V., Hatemi AC. et al. No association between angiotensin-converting enzyme gene polymorphism and left ventricular hypertrophy in hemodialisis patients // Nephron.2000; 84: 130–135.9.

10. West MJ, Summers KM, Wong KK et al.Renin-angiotensin system gene polymorphisms and left ventricular hypertrophy. The case against an association// Adv Exp Med Biol 1997; 432: 117–122